Central Pacific Bank Trust Division Purchases 1,191 Shares of Synopsys, Inc. $SNPS

Central Pacific Bank Trust Division increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 22.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,481 shares of the semiconductor company’s stock after buying an additional 1,191 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Synopsys were worth $3,044,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Brighton Jones LLC raised its position in shares of Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after purchasing an additional 50 shares during the period. Integrated Wealth Concepts LLC grew its position in shares of Synopsys by 11.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock valued at $326,000 after purchasing an additional 79 shares during the period. NewEdge Advisors LLC grew its position in shares of Synopsys by 15.1% in the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock valued at $1,291,000 after purchasing an additional 395 shares during the period. Kingsview Wealth Management LLC increased its stake in Synopsys by 4.0% during the 2nd quarter. Kingsview Wealth Management LLC now owns 751 shares of the semiconductor company’s stock worth $385,000 after purchasing an additional 29 shares in the last quarter. Finally, Empowered Funds LLC increased its stake in Synopsys by 32.8% during the 2nd quarter. Empowered Funds LLC now owns 11,869 shares of the semiconductor company’s stock worth $6,085,000 after purchasing an additional 2,929 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Synopsys Trading Down 1.9%

Shares of Synopsys stock opened at $420.32 on Friday. The business has a fifty day simple moving average of $453.33 and a two-hundred day simple moving average of $458.42. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a market capitalization of $80.52 billion, a price-to-earnings ratio of 65.27, a P/E/G ratio of 3.49 and a beta of 1.15. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26.

Synopsys (NASDAQ:SNPSGet Free Report) last released its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, beating the consensus estimate of $3.56 by $0.21. The firm had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company’s quarterly revenue was up 65.6% on a year-over-year basis. During the same period in the previous year, the company earned $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. Rosenblatt Securities cut their price target on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the stock a “buy” rating in a research report on Wednesday, February 25th. KeyCorp raised their price objective on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Finally, HSBC cut Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a report on Friday, February 20th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $531.00.

View Our Latest Stock Analysis on Synopsys

Insider Activity at Synopsys

In related news, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total value of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.56% of the company’s stock.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.